Atlas Trials

Triple Negative Locally Advanced Non-resectable Breast Cancer

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Triple Negative Locally Advanced Non-resectable Breast Cancer

RecordFirmDate
Randomized Phase II Study of Ixabepilone Alone and Ixabepilone Plus Cetuximab as First-Line Treatment for Female Subjects With Triple Negative Locally Advanced Non-resectable and/or Metastatic Breast Cancer (NCT00633464)R-Pharm2008-06-01

Track Triple Negative Locally Advanced Non-resectable Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.